Severe Aortic Valve Stenosis Clinical Trial
Official title:
The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis
The objective of this study is to evaluate the ACURATE Neo2 in the Middle East population with severe, symptomatic aortic stenosis.
The MENA-TAVI study is an investigator-initiated, prospective, single-arm observational trial. Patients referred for or presenting with severe aortic stenosis requiring an intervention constitute the source population. The Heart Team consisting of interventional cardiologists and cardiovascular surgeons will evaluate the patients by integrating the available clinical data, the predicted 30-day mortality, individual factors affecting mortality such as frailty as well as the estimated life-expectancy and the patient's wishes to finally reach a consensus on the optimal treatment strategy with regards to transcatheter or surgical aortic valve replacement. Patients planned for TAVI will be screened for eligibility. If patients fulfill all inclusion and do not meet exclusion criteria, they will be informed about the study's purpose and course and will be asked for participation and written informed consent. In case of consent, they will be treated by the ACURATE neo2 aortic bioprosthesis. At discharge and at 30 days, the clinical outcomes composing the primary safety endpoint will be captured. Additional clinical, procedural and echocardiographic data will be obtained at discharge and at 30 days for assessment of secondary endpoints. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05552352 -
VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease
|
N/A | |
| Recruiting |
NCT06168123 -
Future Optimal Research and Care Evaluation - Aortic Stenosis
|
||
| Active, not recruiting |
NCT05182307 -
DurAVR™ THV System: First-In-Human Study
|
N/A | |
| Recruiting |
NCT06156592 -
Post Spinal Hemodynamic Changes in Aortic Stenosis and Mitral Regurgitation by VIS Index and Echocardiography
|
||
| Completed |
NCT04259723 -
Virtual Reality Assisted Conscious Sedation During TAVI
|
N/A | |
| Recruiting |
NCT05873816 -
The PROTEMBO Trial
|
N/A | |
| Recruiting |
NCT04128384 -
Infranodal Conduction Time During TAVR as Predictor of HAVB
|
N/A | |
| Recruiting |
NCT05024942 -
LUS in Aortic Stenosis Patients Undergoing TAVR
|
||
| Recruiting |
NCT05283356 -
Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation
|
Phase 4 | |
| Completed |
NCT02224066 -
Platelet Reactivity After TAVI: A Multicenter Pilot Study
|
Phase 4 | |
| Recruiting |
NCT06168370 -
Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation
|
N/A | |
| Recruiting |
NCT05097183 -
Validation of Accurate Commissural Alignment During Transcatheter Aortic Valve Implantation
|
||
| Active, not recruiting |
NCT05712161 -
Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study
|
N/A | |
| Not yet recruiting |
NCT04988243 -
Multi Center Registry of Transcatheter Aortic Valve Replacement in Northeast China
|
N/A |